Intelligencia
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $12M
Investors
- 4
About Intelligencia
Founded in 2017, Intelligencia, Inc.Intelligencia, Inc. specializes in artificial intelligence tools for the pharmaceutical sector, enhancing decision-making through success probability assessments for drugs. The company was founded in 2017 in New York, US, by Dimitrios Skaltsas, who has a background in technology and entrepreneurship.Intelligencia AI specializes in providing advanced artificial intelligence solutions tailored for the pharmaceutical industry, specifically focused on drug development optimization. The company's core offerings include a suite of tools designed to enhance clinical decision-making by assessing the probability of success (PoS) for drugs across various therapeutic areas. These solutions facilitate risk identification, streamline clinical trial design, and enable access to harmonized data for consistent evaluations. Clients benefit from comprehensive data insights, leveraging proprietary ontologies and expert data curation, which are utilized by leading pharmaceutical organizations globally.Intelligencia AI generates revenue through a subscription-based model that provides access to its suite of software-as-a-service (SaaS) products, including the Portfolio Optimizer and Dynamic Benchmarks. Clients engage in business transactions by subscribing to these services, which offer advanced insights and predictive analytics for clinical development projects. The company fosters partnerships with pharmaceutical organizations, enabling them to utilize accurate and transparent PoS assessments at various stages of drug development.Intelligencia, Inc. The company is actively working on new product designs that will be unveiled in the coming year, aiming to strengthen its position in the market. Additionally, Intelligencia intends to expand its reach into new geographic markets, notably aiming to increase its presence in Asia-Pacific by 2023.
Who invested in Intelligencia
4 investors across 1 round
See all investors in Intelligencia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 10, 2021
Amount
$12M
Investors
Questions about Intelligencia
Who invested in Intelligencia?
Intelligencia has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intelligencia raised?
Intelligencia has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Intelligencia last raise money?
Intelligencia's most recent round on record is a Series A, in Aug 2021.
What does Intelligencia do?
Founded in 2017, Intelligencia, Inc.
Where is Intelligencia headquartered?
Intelligencia is headquartered in New York, US.
Which VCs invest in companies like Intelligencia?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Intelligencia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Intelligencia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.